Results 101 to 110 of about 21,018 (198)

A matching‐adjusted indirect comparison of survival outcomes with pirtobrutinib (BRUIN) versus standard of care (SCHOLAR‐2) in relapsed/refractory mantle cell lymphoma previously treated with a covalent Bruton tyrosine kinase inhibitor

British Journal of Haematology, Volume 208, Issue 1, Page 312-316, January 2026.
Georg Heß, Toby A. Eyre, Min‐Hua Jen, Jiewen Zhang, Benjamin Goebel, Sarang Abhyankar, Martin Dreyling   +6 more
wiley   +1 more source

Development and validation of an UHPLC-MS/MS method for simultaneous quantification of ibrutinib and its dihydrodiol-metabolite in human cerebrospinal fluid

, 2018
David Beauvais, J.-F. Goossens, E. Boyle, Ben Allal, Thierry Lafont, Étienne Chatelut, Charles Herbaux, Franck Morschhauser, Stéphanie Genay, Pascal Odou, Cécile Danel   +10 more
openalex   +2 more sources

Different sensitivity of germinal center B cell-like diffuse large B cell lymphoma cells towards ibrutinib treatment [PDF]

, 2014
Xiaohui Zheng, Ning Ding, Yuqin Song, Lixia Feng, Jun Zhu   +4 more
openalex   +1 more source

Efficacy and safety of ibrutinib in Japanese patients with relapsed or refractory mantle cell lymphoma [PDF]

, 2016
Dai Maruyama, Hirokazu Nagai, Noriko Fukuhara, Toshiyuki Kitano, Takayuki Ishikawa, Hirohiko Shibayama, Ilseung Choi, Kiyohiko Hatake, Toshiki Uchida, Momoko Nishikori, Tomohiro Kinoshita, Yoshihiro Matsuno, Tomoaki Nishikawa, Satoko Takahara, Kensei Tobinai   +14 more
openalex   +1 more source

A multi-institutional outcomes analysis of patients with relapsed or refractory DLBCL treated with ibrutinib [PDF]

, 2017
Allison Winter, Daniel J. Landsburg, Anthony R. Mato, Krista M. Isaac, Francisco J. Hernandez‐Ilizaliturri, Nishitha Reddy, Stephen D. Smith, Mazyar Shadman, Mitchell R. Smith, Paolo Caimi, Deepa Jagadeesh, Brian T. Hill   +11 more
openalex   +1 more source

Epigenetic Rewiring of BCR Signaling as a Novel Mechanism of Ibrutinib Resistance in ABC-DLBCL [PDF]

, 2021
Laura Pasqualucci
openalex   +1 more source

Ibrutinib in CLL: benefit for all? [PDF]

Antonio Cuneo, Paolo Ghia
openalex   +1 more source

Ibrutinib-associated alveolar hemorrhageand spontaneous hemothorax [PDF]

, 2022
İsmail Tombul, Muhammet Sayan, Nazlıhan Boyacı Dündar, Asena Dikyar, Şeyma Yıldız, Ali Çelik   +5 more
openalex   +1 more source

Supplementary Figure Legends from MALT1 Inhibition Is Efficacious in Both Naïve and Ibrutinib-Resistant Chronic Lymphocytic Leukemia [PDF]

, 2023
Nakhle S. Saba, Deanna H. Wong, Georges Tanios, Jessica R. Iyer, Patricia Lobelle‐Rich, Eman L. Dadashian, Delong Liu, Lorena Fontán, Erik K. Flemington, Cydney Nichols, Chingiz Underbayev, Hana Safah, Ari Melnick, Adrian Wiestner, Sarah E.M. Herman   +14 more
openalex   +1 more source

Paraneoplastic Pemphigus Associated with B-cell Chronic Lymphocytic Leukemia Treated with Ibrutinib and Rituximab

, 2018
Yuta Ito, Shinichi Makita, Akiko Miyagi Maeshima, Shunsuke Hatta, Tomotaka Suzuki, Sayako Yuda, Suguru Fukuhara, Wataru Munakata, Tatsuya Suzuki, Dai Maruyama, Koji Izutsu   +10 more
openalex   +2 more sources